| NCT ID | NCT06700902 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Temple University |
| Condition | Major Depressive Disorder |
| Study Type | INTERVENTIONAL |
| Enrollment | 300 participants |
| Start Date | 2024-09-01 |
| Primary Completion | 2027-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 300 participants in total. It began in 2024-09-01 with a primary completion date of 2027-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this research is to investigate whether a peer-delivered illness self-management program called Taking Action can help college students with serious mental illnesses. Participants will be randomly assigned to either the experimental condition (Taking Action) or the control condition (information only). Participants in the experimental condition will attend five 2.5-hour Taking Action sessions. Participants will complete three interviews (baseline, post-intervention, and follow-up) to assess how well the program works, is liked, and benefits students clinically and academically. The investigators seek to test the following hypotheses: Compared to controls, students who do the Taking Action program will report greater improvements in mental health self-management attitudes, skills, and behaviors and will report greater improvements in mental health symptoms and recovery, and better academic outcomes.
Eligibility Criteria
Inclusion Criteria: * Currently enrolled in a 2- or 4-year postsecondary educational institution in the United States (and are able to present a valid student ID card) * Experiencing a serious mental illness, as operationalized by either: * A score of 13 or higher on the K-6 Screening Scale for serious mental illness * Self-reported psychiatric diagnosis of schizophrenia-spectrum or major affective disorder and self-reported lifetime functional impairment due to experiencing mental health challenges * 18 years of age or older * Have consistent access to a computer or smartphone and the Internet for communications * No prior WRAP or Taking Action education Exclusion Criteria: * Expected to graduate or complete their program within 2 semesters * Unable to provide informed consent
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06700902 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Major Depressive Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06700902 currently recruiting?
Yes, NCT06700902 is actively recruiting participants. Contact the research team at elizabeth.thomas@temple.edu for enrollment information.
Where is the NCT06700902 trial being conducted?
This trial is being conducted at Philadelphia, United States.
Who is sponsoring the NCT06700902 clinical trial?
NCT06700902 is sponsored by Temple University. The trial plans to enroll 300 participants.